DVA - DaVita Inc.
| Previous Close | 68.53 |
| Open | 68.53 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 67.81 - 68.53 |
| 52 Week Range | 52.51 - 80.71 |
| Volume | 1,266,527 |
| Avg. Volume | 1,606,646 |
| Market Cap | 11.882B |
| Beta | 1.42 |
| PE Ratio (TTM) | 19.62 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- American City Business Journals•4 days ago
These 10 Colorado companies landed on the 2018 Fortune 500
One local company saw its first appearance on the list.
- Moody's•14 days ago
DaVita Inc. -- Moody's assigns Baa3 ratings to DaVita's senior secured term loan add-ons
Moody's Investors Service (Moody's) announced today that it assigned Baa3 ratings to DaVita Inc.'s incremental senior secured term loan A add-ons. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating, Ba2-PD Probability of Default Rating, Baa3 ratings on its other senior secured credit facilities and the Ba3 ratings on its unsecured notes.
- Thomson Reuters StreetEvents•16 days ago
Edited Transcript of DVA earnings conference call or presentation 3-May-18 9:00pm GMT
Q1 2018 DaVita Inc Earnings Call
- Zacks•17 days ago
DaVita (DVA) Beats Q1 Earnings Estimates, Reiterates View
Year-over-year growth in net dialysis and related lab patient service revenues boost DaVita's (DVA) bottom line in Q1.
- Associated Press•21 days ago
DaVita HealthCare: 1Q Earnings Snapshot
The Denver-based company said it had net income of 98 cents per share. Earnings, adjusted to account for discontinued operations, came to $1.05 per share. The results topped Wall Street expectations. The ...
- American City Business Journals•28 days ago
Methodist launching data-sharing program to keep transplant candidates ready to receive
The program shows "how transplantation and dialysis can work together instead of operating in separate silos."
- Zacks•29 days ago
DaVIta (DVA) to Report Q1 Earnings: Is a Beat in Store?
Kidney Care Business and increasing number of dialysis centers are likely to boost DaVita's (DVA) earnings in Q1.
- American City Business Journals•last month
How Highmark and a provider are working to lower the cost of dialysis care
There aren't many end-stage renal disease patients — it's less than 1 percent of the Medicare population — but they're expensive to insurers: Each patient's annual care cost an average $84,550 in 2013, about 7 percent of all Medicare fee-for-service spending.
- Forbes•last month
Buying Binge For UnitedHealth's Optum Is Only Just Beginning
UnitedHealth Group’s Optum is signaling more acquisitions of medical providers lie ahead after UnitedHealth CEO Dave Wichman said executives will be "strong deployers of capital."
- The Wall Street Journal•last month
[$$] UnitedHealth Increases Guidance for Year
UnitedHealth reported a 31% increase in profit for its latest quarter and raised its earnings outlook for the year.
- Moody's•last month
Moody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare
In its latest issue of Healthcare Quarterly, Moody's Investors Service examines how planned mergers between health insurers and other healthcare companies, as well as potential new entrants to the US healthcare ...
- Bloomberg•2 months ago
30,000 Strong and Counting, UnitedHealth Gathers a Doctor Army
Disruptors are circling the health-care industry. UnitedHealth Group Inc., the biggest U.S. health insurer, has built an army of tens of thousands of physicians to fend off invaders.
Markit•2 months agoSee what the IHS Markit Score report has to say about Davita Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DVA. Over the last one-month, outflows of investor capital in ETFs holding DVA totaled $3.27 billion.
- Zacks•2 months ago
DaVita (DVA) Banks on Kidney Care Unit Amid Labor Union Woes
Davita's kidney care unit is gaining prominence worldwide. However, the company is grappling with labor-union woes in California and Ohio.
- Zacks•2 months ago
Is DaVita (DVA) a Great Stock for Value Investors Right Now?
Let's put DaVita (DVA) stock into this equation and find out if it is a good choice for value-oriented investors right now.
- Associated Press•2 months ago
Intel and DSW jump while Qualcomm and DaVita tumble
Stocks that moved substantially or traded heavily on Tuesday: Qualcomm Inc., down $3.11 to $59.70 President Donald Trump blocked Broadcom's effort to buy the rival chipmaker, citing national security concerns. ...
Markit•3 months agoSee what the IHS Markit Score report has to say about Davita Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DVA. Over the last one-month, outflows of investor capital in ETFs holding DVA totaled $16.83 billion.
- Investopedia•3 months ago
Profits or Purpose: A Firm Tries to Deliver Both
Debate still rages around the ability of ESG investments to deliver performance.
GuruFocus.com•3 months agoCharles de Vaulx's IVA Worldwide Fund Discloses Top 4 Buys of 4th Quarter
Fund releases quarterly portfolio
- GuruFocus.com•3 months ago
DaVita Inc (DVA) Files 10-K for the Fiscal Year Ended on December 31, 2017
DaVita Inc (NYSE:DVA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
- Moody's•3 months ago
Moody's: Health insurers' disruptive growth strategies threaten NFP hospital volume and margins
US not-for-profit hospitals will face greater competition, risk of volume declines and margin erosion as the nation's largest commercial health insurers aggressively pursue growth strategies, Moody's Investors ...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of DVA earnings conference call or presentation 13-Feb-18 10:00pm GMT
Q4 2017 DaVita Inc Earnings Call
- American City Business Journals•3 months ago
DaVita eyes acquisitions, share buy-backs with cash windfall
Flush with $4.9 billion in cash from the pending sale of its medical group and as much as $130 million in expected benefits from federal tax reform, DaVita Inc. CEO Kent Thiry said Tuesday that the company will look to repurchase shares, grow its kidney-care business and make “a limited number of investments” in other health-care companies. The comments came during a quarterly earnings call — the Denver-based kidney-care provider’s first since it announced the sale of its disappointing managed-care unit, DaVita Medical Group, in December to Optum. Thiry told the Denver Business Journal the day after the sale announcement that the company will look at the possible acquisition of companies in other areas of health care andt, already had begun looking at opportunities that it could integrate into its existing divisions.
- Zacks•3 months ago
DaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues
Impressive results from Kidney Care business drove DaVita (DVA) in Q4.
Yahoo Finance Video•24 days agoEARNINGS: Pfizer beats on profits and misses on revenue despite Viagra, Lipitor beats
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
